trial

Cognitive Behavior Therapy and Work Outcome

NCTId NCT00810355
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 87 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2015-08-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
87 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2009-10-01
Primary completion
2015-08-06
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Support groupCognitive Behavior TherapyCognitive Remediation

Sponsors

VA Office of Research and DevelopmentLead Sponsor
Indiana UniversityCollaborator

Investigators

1
Paul Lysaker, PhDPrincipal Investigator

Sites

1 total
Indianapolis, United States

Facts & assertions

4 sourced
Enrollment
87
Phase
NA
Primary Completion Date
2015-08-06
Status
COMPLETED
relationships
The graph out of here
drug
Support group
drug
Cognitive Behavior Therapy
drug
Cognitive Remediation
drug
lead_sponsor
VA Office of Research and Development
company
collaborator
Indiana University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Paul Lysaker, PhD
person